IIFL Finance Limited (NSE:IIFL)

Intra-Cellular Therapies Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Interest and Dividend Income	96,179	95,065	98,387	73,660	61,345	54,271
Total Interest Expense	45,709	43,236	38,350	30,946	28,835	25,623
Net Interest Income	50,470	51,828	60,037	42,713	32,510	28,649
Brokerage Commission	4,922	4,856	4,111	2,290	1,532	1,113
Other Revenue	4,525	2,442	2,218	8,238	7,305	4,307
Revenue Before Loan Losses	59,917	59,127	66,366	53,241	41,347	34,069
Provision for Loan Losses	2,475	-133.7	-17	-859.4	-81.6	4,843
Revenue	57,442	59,260	66,383	54,100	41,428	29,226
Revenue Growth (YoY)	-13.77%	-10.73%	22.70%	30.59%	41.75%	13.93%
Salaries & Employee Benefits	19,252	18,888	16,849	13,295	9,307	7,231
Cost of Services Provided	1,382	1,382	2,461	1,247	857.4	546.03
Other Operating Expenses	7,587	8,980	10,624	7,834	5,699	4,026
Total Operating Expenses	45,313	46,332	40,853	33,252	26,123	19,343
Operating Income	12,130	12,928	25,530	20,849	15,306	9,883
Other Non-Operating Income (Expenses)	7.1	7.1	7.9	255.3	35.3	176.2
EBT Excluding Unusual Items	12,137	12,935	25,538	21,104	15,341	10,059
Other Unusual Items	-5,865	-5,865	-	-	-	-
Pretax Income	6,272	7,070	25,719	21,125	15,360	10,048
Income Tax Expense	1,130	1,289	5,977	5,050	3,477	2,440
Earnings From Continuing Ops.	5,142	5,782	19,742	16,076	11,883	7,608
Net Income to Company	5,142	5,782	19,742	16,076	11,883	7,608
Minority Interest in Earnings	-1,901	-1,994	-2,107	-1,073	-3.6	-6.92
Net Income	3,241	3,788	17,635	15,003	11,879	7,601
Net Income to Common	3,241	3,788	17,635	15,003	11,879	7,601
Net Income Growth	-80.07%	-78.52%	17.55%	26.30%	56.28%	51.47%
Shares Outstanding (Basic)	425	418	381	380	379	378
Shares Outstanding (Diluted)	437	434	386	383	381	379
Shares Change (YoY)	11.12%	12.41%	0.77%	0.38%	0.59%	0.06%
EPS (Basic)	7.63	9.07	46.29	39.49	31.33	20.09
EPS (Diluted)	7.41	8.73	45.71	39.18	31.14	20.04
EPS Growth	-82.07%	-80.90%	16.67%	25.82%	55.39%	51.36%
Free Cash Flow	-	-48,415	-88,463	-54,865	16,830	-36,232
Free Cash Flow Per Share	-	-111.63	-229.28	-143.29	44.12	-95.54
Dividend Per Share	-	-	4.000	4.000	3.500	3.000
Dividend Growth	-	-	-	14.29%	16.67%	33.33%
Operating Margin	21.12%	21.82%	38.46%	38.54%	36.95%	33.82%
Profit Margin	5.64%	6.39%	26.57%	27.73%	28.67%	26.01%
Free Cash Flow Margin	-	-81.70%	-133.26%	-101.41%	40.62%	-123.97%
Effective Tax Rate	18.02%	18.22%	23.24%	23.90%	22.64%	24.28%
Revenue as Reported	105,634	102,371	104,905	84,473	70,236	59,897

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.